GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $69,000 | -43.4% | 362,535 | +0.1% | 0.00% | – |
Q2 2016 | $122,000 | -69.3% | 362,335 | -2.7% | 0.00% | – |
Q1 2016 | $397,000 | +17.5% | 372,447 | +62.2% | 0.00% | – |
Q4 2015 | $338,000 | +45.1% | 229,554 | +55.3% | 0.00% | – |
Q3 2015 | $233,000 | -39.9% | 147,851 | -35.2% | 0.00% | – |
Q2 2015 | $388,000 | -13.0% | 228,006 | -28.9% | 0.00% | – |
Q1 2015 | $446,000 | +108.4% | 320,902 | +121.6% | 0.00% | – |
Q4 2014 | $214,000 | -28.7% | 144,835 | -0.4% | 0.00% | – |
Q3 2014 | $300,000 | +2.4% | 145,438 | +52.1% | 0.00% | – |
Q2 2014 | $293,000 | +72.4% | 95,601 | +40.2% | 0.00% | – |
Q1 2014 | $170,000 | +18.9% | 68,171 | +137.1% | 0.00% | – |
Q4 2013 | $143,000 | +1942.9% | 28,753 | +808.5% | 0.00% | – |
Q3 2013 | $7,000 | -36.4% | 3,165 | -38.7% | 0.00% | – |
Q2 2013 | $11,000 | – | 5,165 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
Matisse Capital | 17,000 | $25,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |